dGH in-Site gives researchers the ability to directly visualize and characterize rearrangements at targeted loci in genetic disease patient samples. Using synthetic oligo probes and repeat-free bioinformatic design, dGH in-Site is capable of tracking translocations, inversions, copy number variants, viral integrations and other complex rearrangements with an approximate 2kb resolution.
In-site allows researchers to examine patient samples one cell at a time without having to worry about PCR biases or misrepresentative sequencing averages from heterogeneous cell populations. Instead, as an orthogonal and complementary technique, in-Site allows you to gather the most comprehensive data available in order to help provide as many answers as possible for patients of rare or undiagnosed genetic diseases.
Learn More About dGH in-Site →